Clinical trial
iDose TR Administration in an Office-Based Surgery Setting
NCT07816692
Study timeline
Study start (actual)2026-05-13Date precision: day
Registry last updated2026-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Open Angle Glaucoma (OAG)unresolved
Ocular Hypertension (OHT)unresolved
Interventions
iDose TR (travoprost intracameral implant) 75 µgCOMBINATION_PRODUCT
Sponsors & collaborators
Glaukos Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07816692 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.